What's working
- CredAlliance creates network effects that compound with every payer added.
- Enterprise ARR grew 106%, proving upmarket motion is working.
- Performance guarantees remove procurement risk for health system buyers.
Medallion is not just selling credentialing software. It is building shared infrastructure that makes every payer and provider network dependent on its data layer. With $130M raised, enterprise ARR up 106%, and CredAlliance now live with national payers, this is a company executing a category lockout play. As a founder in AI Healthcare Workforce, you need to know exactly which part of the stack Medallion cannot absorb without diluting its compliance-and-clearinghouse story.
Medallion launched the first national shared credentialing infrastructure, verifying providers once and syndicating records across payer networks. Any workforce tool that depends on credentialing status now has a structural dependency on Medallion's data layer.
ProductThree new product launches (Privileging, Integration Engine, CAQH Management) in the pre-raise period systematically removed the feature moats that smaller competitors relied on. Each module extends how long a customer stays inside Medallion's workflow.
GTMMedallion's pricing page leads with contractual SLA-backed turnaround commitments backed by AI plus expert oversight, which is a procurement-friendly frame for health system budget owners who need accountability, not just automation.
NarrativeThe homepage positions Medallion as the AI operations partner powering healthcare's first real-time Credentials Verification Organization (CVO). That framing is designed to displace legacy CVOs and make AI-native alternatives look like partial substitutes.
ContentThe 2026 State of Payer Enrollment report, an analysis of over 64,000 enrollment records, gives Medallion proprietary benchmark data that competitors cannot replicate, seeding buying conversations with credible, category-defining numbers.
Not raw changes. Directional evidence across product, pricing, content, and market motion.
We track real changes across pricing, positioning, and product. You get clear signals in one place and push them to your team instantly.
Works with the communication tools you already use
Becker's Hospital Review
Confirms enterprise ARR momentum and the CredAlliance clearinghouse as the primary strategic bet, not a secondary feature.
Medical Economics
Independently corroborates the 25 million repeated credentialing events and $1.25B annual cost figure that grounds Medallion's clearinghouse market-size claim.
Public review summary
Reviews across G2, Capterra, and GetApp are broadly positive, with consistent praise for ease of use and responsive support. Recurring criticisms target onboarding friction, limited self-service, and workflow consistency gaps at scale.

Toarn AI
Public signal synthesis
Grade B · Solid sentiment and meaningful review volume on G2 and Capterra, but recurring operational complaints prevent a higher grade.
Sources: G2, Capterra, GetApp, Software Advice
Review volume is healthiest on G2 and Capterra. Software Advice mirrors Capterra content and adds limited incremental signal.
Leadership signal
Derek Lo, CEO and Founder, led the August 2025 Series D announcement and CredAlliance launch directly, signaling that the clearinghouse strategy is a founder-level conviction bet, not a product team initiative.
Executive summary · Read this first
Medallion raised $43M in August 2025, bringing total funding to $130M, and simultaneously launched CredAlliance: a national clearinghouse that verifies providers once and syndicates results across participating payer networks. That is not a product launch. That is a bid to own the shared credentialing rail for U.S. healthcare.
The commercial proof is real. Enterprise ARR grew 106% before the raise. The platform now supports roughly 1 million providers, about 10% of the U.S. workforce, and claims to cut provider intake time from 8 days to under 2 hours. Three new products launched alongside the round: Privileging, Integration Engine, and CAQH Management. Each one closes a gap that previously gave point-solution competitors room to breathe.
For your company, the threat is not that Medallion adds a scheduling tab. The threat is that its data layer becomes the verified source of truth for provider identity and compliance status, making every upstream workforce or scheduling tool dependent on its clearinghouse. If CredAlliance adoption compounds, Medallion controls the enrollment clock, and whoever controls enrollment controls when a provider becomes billable. That is the budget line your team needs to fight for or route around.
Axle Health closed a $10M Series A in May 2025 led by F-Prime, with Y Combinator participating, to scale its AI scheduling and route optimization platform for home healthcare providers.
Planbase launched in November 2025 with $2.1M in seed funding led by Y Combinator to deliver an all-in-one AI workforce management platform covering scheduling, credentialing, and payroll for health clinics.
Bemlo is a YC-backed AI-native scheduling and workforce management platform for healthcare and social care, focused on automated schedule generation that balances care demand with employee preferences.
Noise
Product · Q3 2025 to Q2 2026
Infrastructure lock-in over point-solution competitionMedallion publicly launched CredAlliance, verifying providers once and syndicating the results to participating payer networks, targeting the estimated $1.2B in annual duplicative verification costs across roughly 25 million repeated credentialing events.
Every payer that joins CredAlliance makes Medallion's data layer more valuable to every other payer and provider on the network. That is a classic two-sided network dynamic in a space that previously had none. For scheduling, workforce, and staffing platforms, provider credentialing status is upstream. If Medallion controls that status, it controls the conditions under which providers become deployable and billable.
This is the highest-conviction strategic move Medallion has made. If three to five major national payers commit to CredAlliance by end of 2026, the switching cost for any competing credentialing layer becomes prohibitive. The near-term risk is adoption pace: clearinghouses require both sides to move, and payer procurement cycles are slow. But the direction is clear and the investment is in place.
High impact
Strong: national payer participation confirmed publicly, $43M specifically earmarked for CredAlliance scaling, and CEO statements align with product surface.
Map your credentialing dependencies now. If your platform reads or writes provider compliance status, decide whether to integrate CredAlliance as a data source or build a differentiated verification layer before the network effects compound.
Product · Q2 2025 to Q3 2025
Suite expansion removing adjacent competitor moatsMedallion launched Privileging, Integration Engine, and CAQH Management as net-new products in the period leading up to its Series D raise, expanding from core credentialing into hospital privileging workflows, third-party data integrations, and CAQH profile management.
Each launch removes a capability gap that previously gave workflow-adjacent competitors a reason to exist alongside Medallion. Integration Engine in particular is a direct response to the friction customers cited around connecting Medallion to their EHR and workforce stack. When Medallion owns the integration layer, it reduces the surface area where scheduling and staffing tools can wedge in.
Suite expansion at this pace is sustainable only if implementation quality keeps up. G2 and Capterra reviews flag onboarding clunkiness and workflow inconsistency, which means Medallion's breadth is outrunning its depth in some accounts. That gap is where you have the most room to compete on execution quality.
High impact
Strong: product launches confirmed in official press release and company blog; review platform complaints provide consistent corroboration of the execution risk.
Target accounts where Medallion has expanded module scope but not yet proven integration quality. A tight, well-integrated point solution that does one job perfectly beats a sprawling suite that customers have to manage.
GTM · Q3 2025 to Q2 2026
Accountability-first enterprise positioningMedallion's pricing and homepage now lead with contractual SLA-backed turnaround guarantees, positioning performance guarantees as a primary purchase rationale rather than a secondary feature. The public pricing page explicitly frames outcomes around compliance risk reduction and time-to-revenue.
Health system procurement teams are risk-averse. A vendor that offers contractual guarantees on turnaround times removes the internal political risk for the operations leader signing the contract. That shifts the buying conversation from capability comparison to risk transfer, which is much harder for early-stage competitors to match without a track record.
This framing works best for the health system and large provider group segment. It is less relevant for the digital health startup or small clinic segment, where speed and flexibility matter more than SLAs. If your company targets the latter, you can compete on a very different set of values.
Medium impact
Moderate: pricing and homepage language is consistent, but actual SLA terms are not publicly disclosed, so depth of the contractual commitment is unverified.
Position your product around the outcomes Medallion's SLA framing ignores: scheduling speed, staff flexibility, and patient volume impact. Guarantee outcomes in the operational layer, not just the compliance layer.
Ongoing competitor monitoring
Founders and CEOs competing in AI Healthcare Workforce, including scheduling, credentialing, and workforce management for healthcare organizations.
Signal-based, publicly observable claims only. No private data, no leaked documents.
Sources consulted: Medallion.co homepage, pricing page, solutions pages (credentialing, privileging, monitoring, enrollment), company blog, press releases, third-party reviews on G2, Capterra, GetApp, and Software Advice, CB Insights and Crunchbase profiles, press coverage from Becker's Hospital Review, MobiHealthNews, Medical Economics, and Healthcare IT Today. Archive drift reviewed for homepage and category claims.
This report is compiled from publicly available sources only. No personal data as defined under applicable privacy laws was collected or processed. All analysis reflects editorial interpretation of public signals, not statements of fact. No guarantee is made as to accuracy, completeness, or timeliness. Business decisions based on this report are solely the reader's responsibility. Toarn accepts no liability for outcomes resulting from reliance on this analysis.
Q2 2026 · Updated Apr 11, 2026